Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses

Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses

Abstract A metal nanoparticle composite, namely TPNT1, which contains Au-NP (1 ppm), Ag-NP (5 ppm), ZnO-NP (60 ppm) and ClO2 (42.5 ppm) in aqueous solution was prepared and characterized by spectroscopy, transmission electron microscopy, dynamic light scattering analysis and potentiometric titration...

Full description

Bibliographic Details
Main Authors:	Sui-Yuan Chang, Kuo-Yen Huang, Tai-Ling Chao, Han-Chieh Kao, Yu-Hao Pang, Lin Lu, Chun-Lun Chiu, Hsin-Chang Huang, Ting-Jen Rachel Cheng, Jim-Min Fang, Pan-Chyr Yang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-04-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-87254-3

Similar Items

Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
by: Kuo‐Yen Huang, et al.
Published: (2021-01-01)

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity
by: Hagit Achdout, et al.
Published: (2021-10-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

SARS-CoV-2 and Influenza Virus Coinfection
by: Figen Kaptan
Published: (2020-12-01)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
by: Mitsuru Sada, et al.
Published: (2020-10-01)

Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan
by: Bo-Ruei Huang, et al.
Published: (2021-04-01)

Detection and Differentiation of SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses by CRISPR
by: Huifen Zhou, et al.
Published: (2021-05-01)

Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging.
by: Chung-ke Chang, et al.
Published: (2013-01-01)

Co-infection with SARS-CoV-2 and influenza A virus
by: Shuhei Azekawa, et al.
Published: (2020-01-01)

The origin and underlying driving forces of the SARS-CoV-2 outbreak
by: Shu-Miaw Chaw, et al.
Published: (2020-06-01)

Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China
by: Xiaojing Wu, et al.
Published: (2020-06-01)

MXene–Graphene Field-Effect Transistor Sensing of Influenza Virus and SARS-CoV‑2
by: Yanxiao Li, et al.
Published: (2021-03-01)

Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection
by: Ivonne Melano, et al.
Published: (2021-07-01)

Features and transmission dynamics of SARS-CoV-2 superspreading events in Taiwan: Implications for effective and sustainable community-centered control
by: Yi-Ching Chen, et al.
Published: (2021-07-01)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
by: Kai Chieh Chang
Published: (2021-03-01)

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana
by: Jennifer L. Miatech, et al.
Published: (2020-01-01)

A traditional medicine, respiratory detox shot (RDS), inhibits the infection of SARS-CoV, SARS-CoV-2, and the influenza A virus in vitro
by: Brian Hetrick, et al.
Published: (2021-05-01)

A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response
by: Yi-Chun Lin, et al.
Published: (2020-07-01)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
by: Yong Xia, et al.
Published: (2020-07-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development
by: Sheng-Wen Huang, et al.
Published: (2020-08-01)

Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China
by: Xiangsha Kong, et al.
Published: (2021-06-01)

Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy
by: Elyse Latreille, et al.
Published: (2021-01-01)

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers
by: Iván Martínez-Baz, et al.
Published: (2020-10-01)

Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection
by: Masaaki Miyazawa
Published: (2020-10-01)

From Influenza Virus to Novel Corona Virus (SARS-CoV-2)–The Contribution of Obesity
by: Indranil Bhattacharya, et al.
Published: (2020-10-01)

Liquid Chalk Is an Antiseptic against SARS-CoV-2 and Influenza A Respiratory Viruses
by: Julie L. McAuley, et al.
Published: (2021-06-01)

SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia
by: Ashok Munivenkatappa, et al.
Published: (2021-01-01)

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
by: Stéphanie Bibert, et al.
Published: (2021-05-01)

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
by: Hsing-Yu Hsu, et al.
Published: (2021-08-01)

Role of the Immune Microenvironment in SARS-CoV-2 Infection
by: Chih-Hung Ye, et al.
Published: (2021-05-01)

Vacunas Sars Cov
by: Gutierrez, Manuel
Published: (2021)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Are we still afraid of influenza during the Sars-Cov2 pandemic? - epidemiological analysis of influenza morbidity and vaccination in the 2019/2020 season
by: Kinga Ruszel, et al.
Published: (2020-07-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis
by: Thi Loi Dao, et al.
Published: (2021-09-01)

The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus
by: Raveen Rathnasinghe, et al.
Published: (2021-09-01)

Abnormal liver tests in patients with SARS-CoV-2 or influenza – prognostic similarities and temporal disparities
by: Noa Shafran, et al.
Published: (2021-06-01)